![]() High-throughput SNP/mutation screening by dHPLC often yields large amounts of data that can be formidable to interpret, organize, and archive. With the Helix System, bio-molecular scientists simply place standard polymerase chain reaction (PCR) products into the system, press a button, and obtain results. Industry analysts believe the market for systems used for determining DNA variations to be about $60 million annually. ![]() This information provides researchers with critical supporting data for evaluating an individual's potential risk for cancer and inherited disorders. Clinical researchers use dHPLC to determine if a particular individual possesses a specific DNA mutation. ![]() By studying variations in the DNA sequence across a population, and comparing them to the general population, scientists can better understand the basis of disease. It is based on a dHPLC (denaturing high performance liquid chromatography) platform, includes unique classification software, and the most precise temperature control available for DNA analysis.ĭHPLC is an increasingly critical tool for bio-molecular scientists involved in fundamental DNA research and in applied clinical studies. The first offering from Varian's new BioSolutions™ product initiative, the Helix System is specifically designed as a complete packaged solution for bio-molecular applications including small-scale genotyping, DNA sizing, and oliglionucleotide purification. (Palo Alto, CA) today introduced its next-generation Helix™System for DNA Analysis, a fully automated tool for determining variations in the DNA sequence. ![]() Helix System is first of Varian's new BioSolutions product family ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |